Breaking News

Patheon, JLL Reach Settlement

Patheon's special committee and JLL partners have reached a settlement over their pending legal actions

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The Special Committee of independent directors at Patheon and equity investor JLL Partners Inc. have entered into a settlement agreement in respect of the pending legal actions between the parties. The settlement’s main points include: until March 2011, the Board will consist of nine directors who will initially be four nominees of JLL, the chief executive officer of the company (Wesley P. Wheeler), Joaquin B. Viso and three independent directors. The three independent directors ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters